Envista initiated with an Equal Weight at Wells Fargo

Wells Fargo analyst Vik Chopra initiated coverage of Envista with an Equal Weight rating and $20 price target The firm sees a balanced risk/reward profile and no catalyst for near-term multiple expansion. It looks for consistent execution and a return to market growth rates to get more constructive on the shares. The dental market is sensitive to economic conditions and Envista is underperforming the market, the analyst tells investors in a research note.